2h |
P00041 |
Metabotropic glutamate receptor group I
pathway |
2 |
5.31E-01 |
P02772 |
Pyruvate metabolism |
1 |
1.00E + 00 |
P00019 |
Endothelin signaling pathway |
2 |
1.00E + 00 |
P02746 |
Heme biosynthesis |
1 |
1.00E + 00 |
P00031 |
Inflammation mediated by chemokine and
cytokine signaling pathway |
3 |
1.00E + 00 |
P06664 |
Gonadotropin-releasing hormone receptor
pathway |
3 |
1.00E + 00 |
P00024 |
Glycolysis |
1 |
1.00E + 00 |
P04386 |
Histamine H2 receptor mediated signaling
pathway |
1 |
1.00E + 00 |
P05913 |
Enkephalin release |
1 |
1.00E + 00 |
P00017 |
DNA replication |
1 |
1.00E + 00 |
Day 2 |
P00041 |
Metabotropic glutamate receptor group I
pathway |
2 |
5.79E-01 |
P00017 |
DNA replication |
2 |
5.79E-01 |
P02772 |
Pyruvate metabolism |
1 |
1.00E + 00 |
P02746 |
Heme biosynthesis |
1 |
1.00E + 00 |
P00019 |
Endothelin signaling pathway |
2 |
1.00E + 00 |
P00031 |
Inflammation mediated by chemokine and
cytokine signaling pathway |
3 |
1.00E + 00 |
P06664 |
Gonadotropin-releasing hormone receptor
pathway |
3 |
1.00E + 00 |
P00024 |
Glycolysis |
1 |
1.00E + 00 |
P04386 |
Histamine H2 receptor mediated signaling
pathway |
1 |
1.00E + 00 |
P05913 |
Enkephalin release |
1 |
1.00E + 00 |
Day 4 |
P00029 |
Huntington disease |
2 |
1.00E + 00 |
P00020 |
FAS signaling pathway |
1 |
1.00E + 00 |
P06664 |
Gonadotropin-releasing hormone receptor
pathway |
2 |
1.00E + 00 |
P00016 |
Cytoskeletal regulation by Rho GTPase |
1 |
1.00E + 00 |